Skip to main content
Trulieve Cannabis Corp. logo

Trulieve Cannabis Corp. — Investor Relations & Filings

Ticker · TRUL ISIN · CA89788C1041 LEI · 549300122MBOJDGEZ014 CSE Manufacturing
Open in API
Filings indexed 902 across all filing types
Latest filing 2020-09-22 Capital/Financing Update
Country CA Canada
Listing CSE TRUL

About Trulieve Cannabis Corp.

https://www.trulieve.com/

Trulieve Cannabis Corp. is a leading vertically integrated multi-state operator (MSO) focused on the cultivation, processing, and retail distribution of branded cannabis products across the United States. The company manages the entire supply chain, distributing its offerings through a network of Trulieve branded dispensaries. Trulieve provides a comprehensive portfolio designed for consumer wellness, relaxation, and relief. Product categories include flower, edibles, vapes, concentrates, topicals, and accessories, marketed under various proprietary brands such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, and Momenta. The company's operational model emphasizes accessibility and control over product quality from seed to sale.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing an underwritten offering of subordinate voting shares by Trulieve Cannabis Corp. It details the terms of the offering, the use of proceeds, regulatory approvals, and disclaimers about securities laws. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The content focuses on capital raising activities and share issuance. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is 7590 characters, which is sufficient for a detailed announcement but does not contain financial reports or earnings data. Hence, the classification is CAP with high confidence.
2020-09-22 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of an underwritten offering of subordinate voting shares by Trulieve Cannabis Corp. It details the number of shares offered, the price, the gross proceeds, the use of proceeds, and the underwriters involved. It references the prospectus and regulatory compliance but does not contain financial statements or detailed financial analysis. The document is focused on a financing event (share offering) and is not a full financial report, earnings release, or regulatory filing of financial results. It is not a report publication announcement since it contains substantive information about the financing event itself. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2020-09-21 English
Consent letter of issuer's legal counsel.pdf
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from DLA Piper (Canada) LLP addressed to various Canadian securities commissions regarding a prospectus supplement dated September 17, 2020, for Trulieve Cannabis Corp. It references the prospectus supplement and confirms no misrepresentations in the information derived from their legal opinions. The document is short (1944 characters) and primarily serves as a legal consent and opinion related to a prospectus supplement, which is a financing document. It does not contain financial statements or detailed financial data itself, nor is it a full prospectus or base shelf filing. This type of document is best classified as a Regulatory Filing (RNS) because it is a legal opinion related to a regulatory filing and does not fit other categories such as Capital/Financing Update (CAP) which would be the actual prospectus or supplement itself, nor is it an audit or management report.
2020-09-18 English
Auditors' consent letter.pdf
Regulatory Filings Classification · 95% confidence The document is a letter from auditors providing consent for the use of their audit report in a prospectus supplement related to a securities offering. It references the audit report dated April 7, 2020, on the financial statements for years ended December 31, 2019 and 2018. The letter states it is not an audit or review of the prospectus itself but a consent to use the auditor's report in the offering document. The document length is short (2215 characters) and does not contain actual financial statements or substantive financial data, only a consent statement. According to the rules, such auditor consents or certifications are classified as Regulatory Filings (RNS), not as Audit Reports (AR) or Annual Reports (10-K).
2020-09-18 English
Underwriting or agency agreements (or amendment thereto).pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'AMENDED AND RESTATED UNDERWRITING AGREEMENT' and details terms of a securities offering, including the purchase and sale of subordinate voting shares, purchase price, over-allotment option, and regulatory references such as the Securities Act of 1933 and Canadian securities laws. It is a legal contract related to capital raising and share issuance. There is no indication of financial statements, audit reports, earnings data, or management discussion. The document is not a report or announcement of voting results, nor is it a regulatory filing or certification. It clearly relates to financing activities and capital structure changes through an underwriting agreement for a share offering. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2020-09-18 English
Prospectus (non pricing) supplement (other than ATM) – English.pdf
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement related to a new issue of subordinate voting shares by Trulieve Cannabis Corp. It details the offering price, underwriting agreement, number of shares offered, and related terms. The text includes legal disclaimers about securities registration and distribution, information about the offering process, and details about the share classes and voting rights. This type of document is a capital raising disclosure, specifically a prospectus supplement to a base shelf prospectus, which is used to update or add to the information about a securities offering. It is not an annual report, earnings release, or any other financial report but rather a detailed capital/financing update about a new share issuance. Therefore, the correct classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed offering information support this classification with high confidence.
2020-09-18 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.